Join us at SNMMI 2024 Therapeutics Conference in Bethesda, Maryland this September 19-21. Here's a sneak peek at our Session 1 speakers and their scheduled presentations on Clinical Trials and Research in Therapeutics. https://lnkd.in/eHK7vXgD
Looking forward to this exciting meeting!
The Future of Exosome Based Therapeutics: Key Clinical Updates ZEO ScientifiX™ invites you to a LIVE Webinar on The Future of Exosome Based Therapeutics with Dr. George Shapiro, MD https://lnkd.in/g5pnyr42
Medical Oncologist, Researcher – Minsk City Clinical Oncologic Centre, ESO Ambassador
With such brilliant panel of experts you just can't afford to miss this webinar! #ESMO #PrecisionOncology #biomarkers
The last webinar in the #PrecisionOncology series presents ESMO’s new proposal for a classification of tissue-agnostic therapeutics. Secure your place and have your questions answered by international experts. 👉Register now with your ESMO account: 🔗https://ow.ly/G41o50R95Gk Claudia Cardone, Vivek Subbiah, Sewanti Limaye, Benedikt Westphalen, George Pentheroudakis
FemTech Leader | Board Director | Medical Device Expert | Scientist | The BOLD Nurse Coach & Consultant | MEDSURG Nurse Advocate | Author
It's not too late to attend this webinar today - Pharmacogenomics: Transforming Patient Care
Our first webinar of the year is happening tomorrow! Join us from 2 p.m. - 3 p.m. CT as we cover "Pharmacogenomics: Transforming Patient Care". This is a can't-miss session that will explore all about the basics of pharmacogenomics, implications of testing, current uses of pharmacogenomic therapeutics, and more. Register now: https://hubs.la/Q02hTJj30
The start of a new year is a time to reflect on past accomplishments and future ambitions. This recently published article in the Clinical Leader shares how the FSHD Society-Fulcrum Therapeutics partnership began, how it has evolved over time, and where we hope to go in the future. You can read the whole story here: https://lnkd.in/ekCbQnqP
Discover how we identify participants for our Decoy20 clinical trials at Indaptus Therapeutics. VP of Clinical Operations, Jeffery Nieves explains our thorough process, from collaborating with healthcare professionals across the US to conducting rigorous screenings. Learn about our dedicated approach to selecting the right patients for our studies. #ClinicalTrials #CancerResearch #PatientSafety #biotech #BladderCancer
CONFERENCE UPDATE: The abstract is available for Repare Therapeutics' presentation at ESMO GI from the Phase 1 MINOTAUR trial evaluating lunresertib in combination with FOLFIRI. Learn more here: https://lnkd.in/ebPvugmb #precisiononcology #syntheticlethality #clinicaltrials
Discover how a comprehensive study mapped the interactome of GPCRs and RAMPs, revealing new insights into their complex interactions and potential for targeted therapeutics. Subscribe to the Dr. GPCR Newsletter 📰 and get the latest GPCR News delivered to your inbox ➡️https://bit.ly/3WXdBMd #gpcr #drgpcr
Chief & Director, Cellular Therapy Program. Associate Professor, Children's National & GWU | Cell Therapy Expert | Speaker | Leader
Great to see some positive news in the allogeneic CAR T space. Especially for a disease like Multiple Myeloma where commercial companies have struggled to meet demand. Also interest to see prominent use of a non-viral gene delivery platform, which I think we'll see more of very soon. #CART #celltherapy #genetherapy.
More positive #CARTcellTherapy news for #MultipleMyeloma patients as Poseida Therapeutics, Inc. and Roche's allogeneic product advances in clinical setting with a reported 91% ORR in 23 patients. (From geneng news) https://lnkd.in/guDcJxjP
How can you elevate your oncology drug development program? One way to do so is to provide targeted, comprehensive training to set your CRAs up for success when managing these clinical trials. Get your copy of our white paper today to learn more about the challenges in current training programs, the latest cutting-edge therapeutics, and how our training empowers CRAs to ensure trial efficiency, data integrity, and patient safety: https://ow.ly/PvxZ50TOzKz
Executive BD leader in life sciences with nearly 20 years experience in consultative selling & managing sales teams. Overseeing all commercial activities in RLT and CNS at Perceptive.
2moInvicro/calyx will be there!